This page follows insider dealings at SonoScape Medical Corp. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. SonoScape Medical Corp. has had no insider filing for more than a year; the last one goes back to 30 September 2022.
Since 2021, the database holds no purchases and 5 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Analysts rate SonoScape Medical Corp. Buy (bullish), based on 5 analysts. Average price target: CN¥27.62.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
5 of 5 declarations
开立医疗 is a company focused on the healthcare and pharmaceutical sector, providing innovative medical solutions. It is listed on the XSHE market.